StockWatch
·
Pharmaceuticals
Management Change11 Jul 2026, 05:40 pm

Sandu Pharma Board Reconstitutes Committees, Appoints New Director

AI Summary

Sandu Pharmaceuticals Ltd held a Board of Directors meeting on July 11, 2026. The board noted the demise of Managing Director Shri Umesh B. Sandu. Dr. Neeti Madan Kapre was appointed as an Additional Non-Executive Independent Director for a five-year term. Shri Balram Viswanathan was redesignated from Chairman and Non-Executive Independent Director to Chairman and Managing Director for three years, subject to member approval. Consequently, the Audit Committee, Nomination and Remuneration Committee, and Stakeholders' Relationship Committee were reconstituted.

Key Highlights

  • Board notes demise of MD, Shri Umesh B. Sandu.
  • Dr. Neeti Madan Kapre appointed as Additional Non-Executive Independent Director.
  • Shri Balram Viswanathan redesignated as Chairman and Managing Director.
  • Board committees (Audit, Nomination, Stakeholders) reconstituted.
  • Vigil Mechanism Policy revised.